Download PDF
Semin Musculoskelet Radiol 2013; 17(02): 221-226
DOI: 10.1055/s-0033-1343098
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Musculoskeletal Tumor Imaging: An Orthopedic Oncologist Perspective

Courtney E. Sherman
1   Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida
,
Mary I. O'Connor
1   Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, Florida
› Author Affiliations
Further Information

Publication History

Publication Date:
14 May 2013 (online)

Also available at
    Permissions and Reprints

Abstract

Imaging of a musculoskeletal tumor or lesion is vital for the proper diagnosis and treatment of a patient. There are critical questions for the orthopedic oncologist that musculoskeletal imaging should answer. Is the lesion demonstrating benign or malignant characteristics? Where are the vital structures located in relationship to the lesion? Are there any other regional metastases? Where should an image-guided or open biopsy be performed to allow for limb salvage? What surgical resection will allow adequate margins with the goal of preserving as much function as possible? Decisions regarding biopsies and surgical planning are ideally made by a collaborative discussion between the treating orthopedic oncologist and the radiologist.

Keywords

sarcoma - biopsy - staging - tumor resection - orthopedic oncology
 

  • References

  • 1 O'Connor MI. Musculoskeletal imaging: what information is important to the orthopedic oncologist?. Semin Musculoskelet Radiol 2007; 11 (3) 273-278
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Greenspan A, Jundt G, Remagen W. Differential diagnosis in orthopaedic oncology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007
    Google Scholar
  • 3 Michael AS, Springfield D. Surgery for Bone and Soft-Tissue Tumors. Philadelphia, PA: JB Lippincott; 1998
    Google Scholar
  • 4 Heck RK, O'Malley AM, Kellum EL, Donovan TB, Ellzey A, Witte DA. Errors in the MRI evaluation of musculoskeletal tumors and tumorlike lesions. Clin Orthop Relat Res 2007; 459: 28-33
    CrossrefPubMedGoogle Scholar
  • 5 Peterson JJ. F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors. Semin Musculoskelet Radiol 2007; 11 (3) 246-260 Review
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 1982; 64 (8) 1121-1127
    CrossrefPubMedGoogle Scholar
  • 7 Mankin HJ, Mankin CJ, Simon MA. Members of the Musculoskeletal Tumor Society. The hazards of the biopsy, revisited. J Bone Joint Surg Am 1996; 78 (5) 656-663
    PubMedGoogle Scholar